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ABSTRACT
Common variable immune deficiency disease (CVID) is the most prevalent acquired immune 
deficiency in a human being after selective immunoglobulin A deficiency. It causes reduction 
of immunoglobulin levels and specific antibodies production and enhancement of recurrent and 
chronic infections risk, especially respiratory infections. The CVID patients face increased the 
risk of granulomatous disease, autoimmune and phenomenon, and malignancy. The disease 
involves males and females equally. Some studies showed that early diagnosis of CVID 
disease and conventional treatment of patients with intravenous immunoglobin might have an 
effective role in decreasing pneumonia and frequency of hospitalization due to infections and its 
complications. In this study, we report a 16 years old girl with CVID, without a clinical history 
of determined infection with recurrent sinusitis.
INTRODUCTION
Common variable immune deficiency (CVID) is a primary 
immunodeficiency disease which is associated with decreas-
ing of antibody response and defect in T cell proliferation 
and cytokines secretion especially interlukin-2. Therefore, 
these patients are at high risk of granulomatous disease, au-
toimmune phenomenon, and malignancies (1). Prevalence of 
this disease is 1 per 50,000 persons.
The disease involves males and females equally. The prob-
ability of hypo-gamma globulinemia in a family of CVID 
patients is estimated to be 20%. The onset of disease in ear-
ly age and the close consanguineous relationship of parents 
of patients indicate an autosomal recessive etiology for this 
disease. Overall, the disease characterized by hypo-globulin-
emia and recurrent infections. The respiratory system is one 
of the common organs that involved in CVID patients and 
pneumonia is its most common manifestation (2). Utilization 
of immunoglobulin products (e.g. intravenous immunoglob-
ulin (IVIG)) is an appropriate and selective treatment meth-
od in CVID patients, which cause reduction of infections in 
CVID patients in two recent decades (3,4).
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Some studies showed that early diagnosis of CVID dis-
ease and conventional treatment of patients with IVIG might 
have an effective role in decreasing pneumonia and frequen-
cy of hospitalization due to infections and its complications. 
These patients should be followed up more regular and exact 
to increase life expectancy with high quality with accurate 
and complete consumption of IVIG (5). In this study, we re-
port a 16 years old girl with CVID.
CASE PRESENTATION
A 16-years old female referred to our center with fever and 
sputum cough signs/symptoms. Symptoms of the disease 
had started with sputum coughs in last week despite anti-
biotic therapy. There was no cure observed, and the patient 
suffers fever and worsening of symptoms.
The patient was the first child of her parents whom had 
a close consanguineous relationship and there was a history 
of recurrent respiratory infection in her family. History of 
recurrent infection (at least 6 times a year) was expressed 
during childhood which lasted more than peers and failed to 
respond to treatment well.
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The child had growth disorder, and her growth charac-
teristic (height, weight, and body mass index (BMI) was 
comparable with a 10 years old child. There was no sign of 
puberty in her. There was tenderness of maxillary sinuses in 
both sides and frontal sinus at face touch. In an examination 
of the pharynx, there was green postnasal discharge (PND). 
Lung examination revealed tachypnea with crackles on aus-
cultation. Other examinations findings were normal, and 
there was no lymphadenopathy. In paraclinical surveys, si-
nus radiography showed thickening of maxillary and frontal 
sinuses. Patient treated with broad-spectrum antibiotics as a 
resistant sinusitis. After three days her fever was disrupted, 
and after one week she permitted in a good general condi-
tion with a prescription. After two months patient presented 
again with a recurrence of symptoms, which was treated and 
permitted through a respective recovery (cure). After one 
month, the patient has admitted to hospital with a recurrence 
of symptoms again. Due to recurring of symptoms, she was 
put under further investigations.
Computed tomography (CT) scan of sinuses showed an 
increase in mucosal thickness and presence of fluid in pa-
ranasal sinuses and unilateral tonsillitis. High resonance CT 
(HRCT) scan of lung confirmed bronchiectasis at inferior 
lobes of both sides, with the partial collapse of the right me-
dial lobe and mediastinal lymphadenopathy, that was sugges-
tive for cystic fibrosis or allergic reaction. In laboratory tests, 
high ESR levels and leukocytosis with a shift to the left was 
reported. Patient’s tests results are summarized in Table 1.
According to decrease levels of immunoglobulins and 
recurring infections, diagnosis of CVID raised for this case 
and treated by IVIG. After a 10-day period with twice in-
jection per day, the patient was permitted in good general 
condition and monthly IVIG prescription. During 6-month 
follow-up recurrence of symptoms or opportunistic infec-
tions were not observed.
DISCUSSION
The CVID incidence is 1 case per 25-66 thousand people 
in different populations. It usually becomes symptomatic in 
2nd and 3rd decades of life and after puberty, and 20% of pa-
tients are in childhood (6). Our patient was a 16-years old 
child that had become mature. Based on a study in Iran, the 
average age onset of symptoms was 11 and 12 years for girls 
and boys, respectively (7).
In family and relatives of presented child, there wasn’t 
any similar case of the disease reported. In a study in Ger-
many between 32 children with CVID, only one patient had 
a positive family history (8). In a study which published in 
Iran in 2007 among 69 CVID patients, 10 of them had a 
positive family history (9). The reason for this difference 
may be a high prevalence of consanguineous marriage in 
Iran.
In Iran, most common symptoms are infections. In some 
cases, the disease indicated with autoimmune disorders or 
malignancy. In a study in Tehran most common infection in 
CVID patients was pneumonia and after that sinusitis (9). 
Agha Mohammadi et al. reported most common infection in 
these patients were median otitis, respiratory and gastroin-
testinal systems infections (7). In general, these people are 
susceptible to Streptococcus Pneumoniae and Hemophilus 
Influenza. Also, mycoplasma infections have seen in these 
patients (10).
Pulmonary infection and bronchiectasis were observed 
in our patient. In various studies delayed diagnosis, recur-
rent infections and inadequate treatment were known as lung 
damage cause. However, in some people despite the appro-
priate and timely diagnosis and treatment, pulmonary dis-
ease progress bronchiectasis occurs (7). Respiratory failure 
due to chronic pulmonary infection is one of the common 
reason of death in CVID patients. In a study in Iran, mor-
bidity and mortality rate of these patients reported 20% in a 
25 years’ period (11).
The CVID diagnosis usually delayed due to nonspecific 
symptoms. Therefore, this diagnosis should consider in any 
patient with recurrent infection and low serum immunoglob-
ulin levels. Our patient was diagnosed after 6 months since 
visiting the doctor. In a study in Tehran, the average time 
between outbreaks of symptoms and the CVID diagnosis 
was about 4 years (9). In a study in the United Kingdom, the 
disease was diagnosed in an average two years after the on-
set of symptoms (12). Studies showed that delayed diagnosis 
cause incidence of lasting effects (permanent complications) 
in these patients. Education of physician about primary im-
mune deficient diseases would be effective in reduction of 
burden (disease load) and delayed diagnosis.
CONCLUSION
Our patient was treated with IVIG and had been asymp-
tomatic during the follow-up period. In some studies, IVIG 
prescription causes improvement of patient’s quality of life. 
Delayed diagnosis and treatment of CVID patients can lead 
them to death.
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Table 1. Summary of patient’s test in 3 hospitalization 
period
Variables Amount index (%) Amount
Alkaline 
phosphatase (Alp)
1731 (CD3%) 91.09
C-reactive 
protein (CRP)
3+ (CD4%) 33.36
WBC 8041 (CD%) 2.99
PMN 51% (CD16%) 3.06
C3 154 (CD19%) 56.05
C4 78 IgA (mg/dl) Undetectable
Ch50 118 IgG (mg/dl) 90
ESR 31 IgM (mg/dl) 216
IgG (n.l: 7–17g/L), IgM (n.l: 0.4–2.8 g/L), IgA (n.l: 0.7–4 g/L) 
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